FCCC LOGO Faculty Publications
Kirschner M , Bornemann A , Schubert C , Gezer D , Kricheldorf K , Isfort S , Brummendorf TH , Schemionek M , Chatain N , Skorski T , Koschmieder S
Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasms
Ann Hematol. 2019 Nov 20;98(12) :2703-2709
Back to previous list
Abstract
Philadelphia negative (Ph-neg) myeloproliferative neoplasms (MPN) are a heterogenous group of clonal stem cell disorders. Approved treatment options include hydroxyurea, anagrelide, and ruxolitinib, which are not curative. The concept of synthetic lethality may become an additional therapeutic strategy in these diseases. In our study, we show that DNA repair is altered in classical Ph-neg MPN, as analyzed by gene expression analysis of 11 genes involved in the homologous recombination repair pathway (HRR), the non-homologous end-joining pathway (NHEJ), and the single-strand break repair pathway (SSB). Altogether, peripheral blood-derived cells from 57 patients with classical Ph-neg MPN and 13 healthy controls were analyzed. LIG3 as an essential part of the SSB was significantly lower expressed compared to controls in all three entities (essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF)). In addition, while genes of other DNA-repair pathways showed-possibly compensatory-increased expression in ET (HRR, NHEJ) and PV (NHEJ), MF samples displayed downregulation of all genes involved in NHEJ. With regard to the JAK2 mutational status (analyzed in ET and MF only), no upregulation of the HRR was detected. Though further studies are needed, based on these findings, we conclude that synthetic lethality may become a promising strategy in treating patients with Ph-neg MPN.
Notes
1432-0584 Kirschner, Martin ORCID: http://orcid.org/0000-0002-4556-6353 Bornemann, Anne Schubert, Claudia Gezer, Deniz Kricheldorf, Kim Isfort, Susanne Brummendorf, Tim H Schemionek, Mirle Chatain, Nicolas Skorski, Tomasz Koschmieder, Steffen DFG KO 2155/6-1/Deutsche Forschungsgemeinschaft (DE) Journal Article Germany Ann Hematol. 2019 Nov 20. pii: 10.1007/s00277-019-03836-2. doi: 10.1007/s00277-019-03836-2.